Tegeline



Indications and Reactions:

Role Indications Reactions
Primary
Kawasaki's Disease 100.0%
Drug Ineffective 50.0%
Meningitis Aseptic 50.0%
Secondary
Product Used For Unknown Indication 33.6%
Drug Use For Unknown Indication 23.4%
Lewis-sumner Syndrome 5.1%
Optic Neuropathy 4.3%
Acute Polyneuropathy 3.4%
Dermatomyositis 3.4%
Off Label Use 3.0%
Meningitis Pneumococcal 2.8%
Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii Stage Iii 2.6%
Hypertension 2.6%
Polyneuropathy 2.6%
Neuropathy Peripheral 2.3%
Demyelinating Polyneuropathy 1.7%
Influenza Like Illness 1.7%
Micturition Disorder 1.5%
Analgesic Therapy 1.3%
Erythema 1.3%
Neuralgia 1.3%
Sedation 1.3%
Pneumococcal Bacteraemia 1.1%
Renal Failure Acute 14.1%
Stevens-johnson Syndrome 10.6%
Nail Disorder 9.4%
Psoriasis 8.2%
Pulmonary Embolism 8.2%
Optic Neuropathy 5.9%
Renal Tubular Disorder 5.9%
Hepatitis 4.7%
Toxic Skin Eruption 4.7%
Hypertension 3.5%
Neutropenia 3.5%
Vomiting 3.5%
Hypocapnia 2.4%
Oedema Peripheral 2.4%
Renal Failure 2.4%
Sepsis 2.4%
Shock Haemorrhagic 2.4%
Tonsillitis 2.4%
Visual Field Defect 2.4%
Bronchopulmonary Aspergillosis 1.2%
Concomitant
Product Used For Unknown Indication 52.9%
Chronic Lymphocytic Leukaemia 9.5%
Lung Transplant 6.3%
Dermatomyositis 3.7%
Urinary Tract Infection 3.2%
Drug Use For Unknown Indication 2.1%
Lung Disorder 2.1%
Aplastic Anaemia 1.6%
Bone Marrow Conditioning Regimen 1.6%
Bone Marrow Transplant 1.6%
Granulomatosis With Polyangiitis 1.6%
Hypertension 1.6%
Immunomodulatory Therapy 1.6%
Pain 1.6%
Pneumonia Herpes Viral 1.6%
Polymyositis 1.6%
Prophylaxis Against Graft Versus Host Disease 1.6%
Pulmonary Arterial Hypertension 1.6%
Unevaluable Event 1.6%
Chronic Inflammatory Demyelinating Polyradiculoneuropathy 1.1%
Thrombocytopenia 25.0%
Weight Decreased 10.0%
Vomiting 7.5%
Blood Amylase Increased 5.0%
Cytolytic Hepatitis 5.0%
Hemiparesis 5.0%
Hepatocellular Damage 5.0%
Hepatocellular Injury 5.0%
Pyrexia 5.0%
Acute Coronary Syndrome 2.5%
Adenocarcinoma Pancreas 2.5%
Aspartate Aminotransferase Increased 2.5%
Asthma 2.5%
Bronchopulmonary Aspergillosis 2.5%
Cholestasis 2.5%
Colitis Ischaemic 2.5%
Cough 2.5%
Drug Reaction With Eosinophilia And Systemic Symptoms 2.5%
Dyspnoea 2.5%
Eating Disorder 2.5%